# US 2024/0198086 A1 · Vagal nerve stimulation for treating central nervous sytem disorders

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0198086 A1
- Document ID: US20240198086A1
- Status: Published application
- Kind: A1
- Application number: 18/593,513
- Filed: 2024-03-01
- Published: 2024-06-20
- Earliest claimed: 2010-08-19
- Assignees: ElectroCore, Inc.
- Applicants: ElectroCore, Inc.
- Inventors: Bruce J. Simon; Joseph P. Errico
- Web page: https://patentgrep.com/patent/US20240198086A1

## CPC

- A61N 1/0456: {Specially adapted for transcutaneous electrical nerve stimulation [TENS]}
- A61N 1/04: Electrodes {(electrosurgical electrodes A61B18/14)}
- A61N 1/0492: {Patch electrodes (A61N1/0412, A61N1/0428 take precedence)}
- A61N 1/0551: {Spinal or peripheral nerve electrodes}
- A61N 1/36014: {External stimulators, e.g. with patch electrodes (external pacemakers A61N1/3625)}
- A61N 1/36025: {for treating a mental or cerebral condition}
- A61N 1/36034: {specified by the stimulation parameters}
- A61N 1/0472: {Structure-related aspects}
- A61N 1/36017: {with leads or electrodes penetrating the skin}
- A61N 1/36114: {Cardiac control, e.g. by vagal stimulation (stimulating the heart A61N1/362)}
- A61N 1/40: Applying electric fields by inductive or capacitive coupling (microwave apparatus A61N5/00); {Applying radio-frequency signals}
- A61N 2/006: {for magnetic stimulation of nerve tissue}
- A61N 2/008: {for pain treatment or analgesia}
- A61N 2/02: using magnetic fields produced by coils, including single turn loops or electromagnets (A61N2/12 takes precedence)
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)

## Abstract

Devices and methods are disclosed for treating one or more symptoms of a central nervous system disorder in a patient, such as fibromyalgia, anxiety, traumatic brain injury or post-traumatic stress disorder (PTSD). A device comprises one or more electrodes configured for contacting an outer skin surface of the patient and an energy source coupled to the electrodes. The energy source generates at least one electrical impulse and transmits the electrical impulse transcutaneously from the electrodes through the outer skin surface of the patient to a vagus nerve in the patient. The electrical impulse comprises a burst period and a constant period. Each burst period comprises 2 to 20 pulses that alternate between a positive and negative electric field charge and at least a portion of each constant period comprises zero pulses. The electrical impulse is sufficient to modify the vagus nerve such that the symptoms of the disorder are reduced.

## Claims

### Claim 1

A device for treating symptoms of a central nervous system disorder in a patient, the device comprising:
at least one electrode configured for contacting an outer skin surface of the patient; and
an energy source coupled to the electrode, wherein the energy source is configured to generate at least one electrical impulse and to transmit the electrical impulse transcutaneously from the electrode through the outer skin surface of the patient to a vagus nerve in the patient; and
wherein the electrical impulse comprises a burst period and a constant period, wherein each burst period comprises 2 to 20 pulses and at least a portion of each constant period comprises zero pulses, wherein the pulses alternate between a positive and negative electric field charge within each burst period, wherein the electrical impulse is sufficient to modify the vagus nerve such that the symptoms of the central nervous system disorder are reduced.

### Claim 2 (depends on 1)

The device of claim 1, wherein the electrical impulse is administered according to a stimulation protocol that includes at least one dose having a duration of thirty seconds to about five minutes.

### Claim 3 (depends on 2)

The device of claim 2, wherein the stimulation protocol includes administering two or more doses each day for a plurality of days.

### Claim 4 (depends on 2)

The device of claim 2, wherein the duration of each dose is about ninety seconds to about three minutes.

### Claim 5 (depends on 1)

The device of claim 1, wherein the energy source is wirelessly coupled to the one or more electrodes.

### Claim 6 (depends on 1)

The device of claim 1, further comprising an electrical connector coupling the energy source to the one or more electrodes.

### Claim 7 (depends on 1)

The device of claim 1, wherein the one or more electrodes are configured for attachment to the outer skin surface of the neck of the patient.

### Claim 8 (depends on 1)

The device of claim 1, further comprising a housing, wherein the energy source is housed within the housing and the electrodes are attached to, or incorporated into, the housing.

### Claim 9 (depends on 1)

The device of claim 1, further comprising a controller coupled to the energy source and configured to transmit parameters for the stimulation protocol to the energy source.

### Claim 10 (depends on 3)

The device of claim 3, wherein each of the doses are separated by a time frame of about five to 15 minutes.

### Claim 11 (depends on 1)

The device of claim 1, wherein the pulses have a frequency of about 1 kHz to about 20 KHz.

### Claim 12 (depends on 1)

The device of claim 1, wherein each burst period has a frequency of about 1 to about 100 bursts per second and each pulse has a duration of about 50 to about 1000 microseconds in duration.

### Claim 13 (depends on 1)

The device of claim 1, wherein the electrical impulse is sufficient to cause release of one or more inhibitory neurotransmitters in a brain of the patient.

### Claim 14 (depends on 13)

The device of claim 13, wherein the inhibitory neurotransmitters comprise one of GABA, serotonin, or norepinephrine.

### Claim 15 (depends on 1)

The device of claim 1, wherein the central nervous system disorder comprises fibromyalgia.

### Claim 16 (depends on 1)

The device of claim 1, wherein the central nervous system disorder comprises an anxiety disorder.

### Claim 17 (depends on 1)

The device of claim 1, wherein the central nervous system disorder comprises PTSD.

### Claim 18 (depends on 1)

The device of claim 1, wherein the central nervous system disorder comprises traumatic brain injury.
